SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 399 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,993,000 | -18.8% | 23,500 | -44.8% | 0.06% | -30.6% |
| Q1 2020 | $4,915,000 | +42.9% | 42,600 | +41.5% | 0.08% | +77.1% |
| Q4 2019 | $3,439,000 | +316.8% | 30,100 | +98.4% | 0.05% | +700.0% |
| Q4 2017 | $825,000 | 0.0% | 15,171 | 0.0% | 0.01% | -53.8% |
| Q3 2017 | $825,000 | -13.3% | 15,171 | -17.5% | 0.01% | -18.8% |
| Q2 2017 | $952,000 | -16.8% | 18,400 | +1.1% | 0.02% | -27.3% |
| Q1 2017 | $1,144,000 | +19.2% | 18,200 | 0.0% | 0.02% | +10.0% |
| Q4 2016 | $960,000 | – | 18,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |